
The latest hobgoblin to perplex the eating disorder community is the use of GLP-1 medications. Competing presentations and articles are being published. Accusations of bias are already bandied about. This raises the inevitable question … was the talk or article biased or was it simply incomplete?
That distinction matters more than it may first appear. To call a presentation “biased” is to suggest a fundamental defect. It implies bad faith, intellectual contamination, or a failure so basic that the speaker’s credibility is diminished. The word often operates as an accusation, and once it enters the lexicon, the conversation itself changes. People retreat into defensive positions. Groups harden. The possibility of productive engagement narrows.
But to refer to a presentation as “incomplete” is different. “Incomplete” does not excuse weakness. It identifies it with precision. It says the subject required more voices, more context, more rigor, more disciplines, more lived experience, more challenge. It leaves room for the possibility that the presenter was building something rather than distorting something. It invites participation rather than condemnation. It allows the field to ask; What is missing? Who was not included? What assumptions were left untested? What would make this stronger?
That distinction, bias versus incompleteness, goes to the heart of a systemic problem within the eating disorder community.
Too often the field does not possess the structures necessary to metabolize disagreement. It does not consistently bring opposing views into disciplined, accountable deliberation. Instead, it allows major questions to emerge through fragmented presentations, isolated publications, advocacy statements, rebuttals, counter-rebuttals, and public controversy. The result is not consensus. It is not clarity. It is not reform. It is serial reaction and in some cases, overreaction.
Terminal anorexia, weight stigma, obesity, residential treatment, involuntary care, medical stabilization, private equity, insurance denial and the role of families. The debate over GLP-1 medications is only the latest example.
Given the stakes, the introduction of GLP-1s into the eating disorder conversation should have triggered a process proportionate to the seriousness. These medications raise profound clinical, ethical, metabolic, psychological, social and even spiritual questions. They implicate body weight, appetite, medical risk, obesity treatment, relapse vulnerability, access to care, stigma, autonomy, coercion, and the meaning of recovery itself.
A mature field would have responded by convening a serious, multidisciplinary process. Not a panel designed to affirm one position. Not a paper written from one perspective. Not a series of advocacy reactions after the fact. A real process.
That process should have included eating disorder clinicians, obesity medicine specialists, psychiatrists, endocrinologists, researchers, ethicists, patients, families, disability-rights advocates, theologians, legal scholars, and people with lived experience across different diagnostic and body size realities. It should have directly examined assumptions. It should have asked what is known, what is unknown, what is being inferred, and what risks are being underestimated. It should have distinguished clinical concern from ideological reflex. It should have clarified where caution is warranted and where fear may be substituting for evidence.
Instead, the field did what it too often does. It processed the issue through fragmentation.
One group speaks. Another group objects. A paper appears. A blog responds. A statement circulates. A conference panel frames the issue one way. A counter-panel frames it another. Advocates describe harm. Clinicians defend nuance. Researchers ask for data. Patients feel unseen. Families remain confused. Positions harden before the field has created a shared table at which those positions can be tested.
And nothing durable is built. This is not structured deliberation. It is intellectual trench warfare. This trench warfare has become the eating disorder field’s primary method of adjudication.
What does not emerge is institutional architecture capable of absorbing disagreement and converting it into accountable consensus. That absence is not a minor procedural flaw. It is one of the field’s central weaknesses.
A field dealing with a life-threatening illness cannot rely on sequential publication as its primary conflict resolution mechanism. Publication has value. Scholarship matters. Commentary matters. Advocacy matters. But none of those alone can substitute for a legitimate consensus building structure. Papers do not cross-examine assumptions in real time. Advocacy statements do not reconcile competing clinical realities. Conference talks do not create binding standards. Public rebuttals do not necessarily produce shared definitions.
They often produce only more hardened factions.
A system that can only process new and consequential concepts through this fragmented process is not demonstrating intellectual vitality. It is demonstrating procedural weakness. It is showing that it lacks the mechanisms needed to test its most important ideas before they migrate into practice, policy, treatment settings, insurance decisions and public discourse.
That matters because ideas in this field are not abstract. They become clinical posture. They influence whether patients are hospitalized or discharged. They shape how risk is understood. They affect whether families are included or marginalized. They determine whether weight loss is celebrated, feared, treated, or ignored. They define whether a patient is viewed as resistant, autonomous, hopeless, harmed, empowered, or in need of urgent intervention.
Language becomes practice. Practice becomes outcome. Outcome becomes life or death.
The eating disorder community cannot continue treating disagreement as contamination. It cannot keep mistaking opposition for hostility. It cannot continue allowing each faction to speak from its own platform while pretending that the existence of multiple platforms equals meaningful discourse. It does not.
Real discourse requires structure. It requires shared rules. It requires the willingness to sit beside a person who sees the issue differently and remain engaged long enough to understand why. It requires humility from researchers, clinicians, advocates, families, and patients alike. It requires the recognition that no single constituency owns the truth. Separate truths may coexist. A serious field must be able to hold both simultaneously.
The current model does not do that well. The current model rewards position taking more than integration. It rewards rapid response more than disciplined synthesis. It rewards moral clarity, even when the underlying issue is clinically and ethically complex. It allows organizations to issue statements, scholars to publish frameworks, advocates to mobilize outrage, and clinicians to continue practicing amid uncertainty … without requiring the field as a whole to reconcile competing truths.
That is not consensus. That is convenience.
The path forward is not silence. It is not politeness for its own sake. It is not pretending that all views are equally supported by evidence. Some arguments are stronger than others. Some claims are dangerous. Some assumptions deserve to be challenged directly. But the challenge must be structured.
The field needs a new model for consequential disagreement. When the next major issue arises the response should not be another isolated paper followed by predictable backlash. It should be a convened process with opposing experts, clear questions, transparent assumptions, defined evidentiary standards, patient and family participation, ethical review, and a published consensus document that identifies agreement, disagreement, uncertainty, and practical guidance.
Not every issue will end in unanimity. It should not. Forced consensus can be as dangerous as fragmentation. But a credible process can at least clarify the boundaries of disagreement. It can say … here is what we know; here is what we do not know; here is where clinical caution is justified; here is where ideology may be exceeding evidence; here is where patient safety requires action; here is where further research is essential; here is how families and clinicians should proceed in the meantime.
That would be progress.
The eating disorder field does not suffer from a lack of passion. It suffers from a lack of integrative structure. It has brilliant clinicians, committed researchers, courageous patients, grieving families, thoughtful advocates, and people of genuine moral seriousness. But intelligence distributed across factions does not automatically become wisdom. Wisdom requires architecture.
The eating disorder community must move beyond the zero-sum game. It must stop treating incompleteness as bias and disagreement as betrayal. It must build the institutional capacity to hold complexity without collapsing into camps. It must recognize that the goal is not for one tribe to defeat another. The goal is to produce better care, better standards, better evidence, better ethics, and better outcomes.
Lives depend on whether the field can learn to do that.













